| Financial Year |
March 31 2023 |
| Monetary Funds |
1,808,066,116.48 |
| Held-for-trading Financial Assets |
120,107,138.95 |
| Notes Receivable |
27,564,999.11 |
| Accounts Receivable |
607,019,997.50 |
| Advances to Suppliers |
13,824,622.74 |
| Other Receivables |
9,690,179.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
240,517,000.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
32,696,207.99 |
| Total Current Assets |
2,865,850,224.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
12,254,068.52 |
| Investment Properties |
280,776,561.43 |
| Fixed Assetes |
217,064,670.67 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
275,925,702.08 |
| R&D expenses |
71,299,401.70 |
| Goodwill |
1,460,199,322.54 |
| Long-Term Deferred and Prepaid Expenses |
388,605.48 |
| Deferred Income Tax Assets |
59,652,452.05 |
| Other Non-Current Assets |
429,525,300.00 |
| Sub-Total of Non-Current Assets |
3,035,414,609.04 |
| Total Assets |
5,901,264,833.11 |
| Short-Term Loans |
70,069,055.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
354,343,117.93 |
| Accounts Received In Advance |
3,463,287.39 |
| Employee Compensation Payable |
69,115,911.45 |
| Taxes Payable |
84,509,016.63 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
59,139,649.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,502,535.61 |
| Other Current Liabilities |
8,339,948.20 |
| Sub-Total of Current Liabilities |
819,481,550.92 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
18,755,782.89 |
| Deferred Income Tax Liabilities |
2,027,134.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
32,790,632.49 |
| Total Liabilities |
852,272,183.41 |
| Paid-In Capital(Or Share Stock) |
1,961,091,984.00 |
| Capital Surplus |
609,647,689.45 |
| Surplus Reserve |
250,500,186.52 |
| LESS:Treasury Stock |
50,018,299.38 |
| Undistributed Profits |
2,314,856,513.93 |
| Minority Stockholder's Interest |
11,759,849.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,037,232,800.33 |
| Owner's Equity（Stockholder's Equity） |
5,048,992,649.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,901,264,833.11 |
